https://scholars.lib.ntu.edu.tw/handle/123456789/543731
標題: | Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis | 作者: | WEI-CHOU LIN Chen S.-C. Hu F.-C. SHIH-CHIEH CHUEH YEONG-SHIAU PU HONG-JENG YU KUO-HOW HUANG |
公開日期: | 2009 | 卷: | 74 | 期: | 6 | 起(迄)頁: | 1264-1269 | 來源出版物: | Urology | 摘要: | Objectives: To investigate the expression of stathmin in upper urinary tract (UUT) urothelial carcinoma (UC) in human tissues and to determine whether the level of stathmin expression was correlated with prognosis because overexpression of stathmin has been observed in various malignancies. Methods: We first analyzed stathmin mRNA level in 5 UUT-UC paired fresh specimens (tumor and nontumoral urothelium) by RT-PCR. Besides, a total of 58 patients with localized UUT-UC (pT1-3N0M0) treated by nephroureterectomy were enrolled. The stathmin expression in UUT-UC specimens was analyzed by immunohistochemical (IHC) staining. Stathmin IHC score was defined as the proportion of positive staining tumor cells from each patient's specimen. The stathmin IHC score ? 0.5 was defined as strong (+) immunoreactivity and < 0.5 as weak (-) immunoreactivity. Results: Significant differences in stathmin mRNA between UUT-UC and paired normal urothelium were noted in 5 of the patients. Of the 58 UUT-UC specimens, stathmin immunoreactivity (strong [+] vs weak [-]) was significantly associated with pT stage (P = .006) as well as with recurrence-free and cancer-specific survival. In multivariate analysis, stathmin IHC score was a significant predictor for both recurrence-free survival (hazard rates: 22.4; P = .001) and cancer-specific survival (hazard rates: 39.8; P = .0012). Conclusions: The stathmin immunostaining is a novel prognosticator for patients with localized UUT-UC stathmin may be a help identify such patients with poor outcomes to benefit from receiving close follow-up and early adjuvant therapy. ? 2009 Elsevier Inc. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-70749116365&doi=10.1016%2fj.urology.2009.04.088&partnerID=40&md5=8147cb8f847c7f835cc2c37e8848bd5e https://scholars.lib.ntu.edu.tw/handle/123456789/543731 |
ISSN: | 0090-4295 | DOI: | 10.1016/j.urology.2009.04.088 | SDG/關鍵字: | messenger RNA; stathmin; adult; aged; article; cancer recurrence; cancer staging; cancer survival; controlled study; female; gene expression; human; human cell; human tissue; immunohistochemistry; immunoreactivity; major clinical study; male; nephroureterectomy; priority journal; prognosis; reverse transcription polymerase chain reaction; tumor cell; urinary tract carcinoma; urogenital tract tumor; urothelium; Aged; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; RNA, Messenger; Stathmin; Ureteral Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。